Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-09-22

Clinical Trial Update: Intermetatarsal Bursitis in Patients With Rheumatoid Arthritis [NA]

View source ↗

Summary

A clinical trial (NCT05698563) investigating intermetatarsal bursitis in patients with rheumatoid arthritis was terminated; sponsor is Rigshospitalet, Denmark.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Rigshospitalet, Denmark | Conditions: Intermetatarsal Bursitis, Rheumatoid Arthritis | NA | Status: TERMINATED